Microglial Cells Are Involved in the Susceptibility of NADPH Oxidase Knockout Mice to 6-Hydroxy-Dopamine-Induced Neurodegeneration

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Hernandes, Marina S ^a   Santos, Graziella D R ^a   Café Mendes, Cecília C ^a   Lima, Larissa S ^a   Scavone, Cristoforo ^a   Munhoz, Carolina D ^a   Britto, Luiz R G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; APOMORPHINE; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MINOCYCLINE; OXIDOPAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; GENE; GENE EXPRESSION; INFLAMMATION; MALE; MICROGLIA; MOUSE; NERVE DEGENERATION; NONHUMAN; NOX1 GENE; NOX2 GENE; PARKINSON DISEASE; SUBSTANTIA NIGRA; WILD TYPE;

ANIMALS; APOMORPHINE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; INFLAMMATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MINOCYCLINE; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; NERVE DEGENERATION; NF-KAPPA B; OXIDOPAMINE; PARKINSON DISEASE; SUBSTANTIA NIGRA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884504550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075532     Document Type: Article

References (51)

1. Babior BM, (2002) The activity of leukocyte NADPH oxidase: regulation by p47PHOX cysteine and serine residues. Antioxid Redox Signal 4: 35-38. doi:10.1089/152308602753625834. PubMed: 11970841.
2. Babior BM, Lambeth JD, Nauseef W, (2002) The neutrophil NADPH oxidase. Arch Biochem Biophys 397: 342-344. doi:10.1006/abbi.2001.2642. PubMed: 11795892.
3. Bedard K, Krause KH, (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313. doi:10.1152/physrev.00044.2005. PubMed: 17237347.
4. Ibi M, Katsuyama M, Fan C, Iwata K, Nishinaka T, et al. (2006) NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth. Free Radic Biol Med 40: 1785-1795. doi:10.1016/j.freeradbiomed.2006.01.009. PubMed: 16678016.
5. Vallet P, Charnay Y, Steger K, Ogier-Denis E, Kovari E, et al. (2005) Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132: 233-238. doi:10.1016/j.neuroscience.2004.12.038. PubMed: 15802177.
6. Hernandes MS, Britto LR, (2012) NADPH oxidase and neurodegeneration. Curr Neuropharmacol 10: 321-327. doi:10.2174/157015912804499483. PubMed: 23730256.
7. Abramov AY, Canevari L, Duchen MR, (2004) Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta 1742: 81-87. doi:10.1016/j.bbamcr.2004.09.006. PubMed: 15590058.
8. Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, et al. (2002) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem 81: 1285-1297. doi:10.1046/j.1471-4159.2002.00928.x. PubMed: 12068076.
9. Kumar A, Singh BK, Ahmad I, Shukla S, Patel DK, et al. (2012) Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity. Brain Res 1438: 48-64. doi:10.1016/j.brainres.2011.12.028. PubMed: 22244881.
10. Mangano EN, Litteljohn D, So R, Nelson E, Peters S, et al. (2011) Interferon-gamma plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiol Aging.33(7):: 1411-26.
11. Choi SH, Aid S, Kim HW, Jackson SH, Bosetti F, (2012) Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. J Neurochem 120: 292-301. doi:10.1111/j.1471-4159.2011.07572.x. PubMed: 22050439.
12. Gao HM, Liu B, Hong JS, (2003) Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 23: 6181-6187. PubMed: 12867501.
13. Rodriguez-Pallares J, Rey P, Parga JA, Muñoz A, Guerra MJ, et al. (2008) Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol Dis 31: 58-73. doi:10.1016/j.nbd.2008.03.003. PubMed: 18499466.
14. Choi DH, Cristóvão AC, Guhathakurta S, Lee J, Joh TH, et al. (2012) NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. Antioxid Redox Signal 16: 1033-1045. doi:10.1089/ars.2011.3960. PubMed: 22098189.
15. Rodriguez-Pallares J, Parga JA, Muñoz A, Rey P, Guerra MJ, et al. (2007) Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. J Neurochem 103: 145-156. PubMed: 17573824.
16. Schober A, (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318: 215-224. doi:10.1007/s00441-004-0938-y. PubMed: 15503155.
17. Zhang W, Wang T, Qin L, Gao HM, Wilson B, et al. (2004) Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J 18: 589-591. PubMed: 14734632.
18. Molina-Luna K, Pekanovic A, Röhrich S, Hertler B, Schubring-Giese M, et al. (2009) Dopamine in motor cortex is necessary for skill learning and synaptic plasticity. PLOS ONE 4: e7082. doi:10.1371/journal.pone.0007082. PubMed: 19759902.
19. Paxinos G, Franklin K, (2007) The Mouse Brain in Stereotaxic Coordinates. New York: Academic Press. 360pp.
20. Dussault AA, Pouliot M (2006) Rapid and simple comparison of messenger RNA levels using real-time PCR. Biol Proced Online 8: 1-10. doi:10.1251/bpo114. PubMed: 16446781.
21. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, et al. (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22: 1763-1771. PubMed: 11880505.
22. Hernandes MS, Britto LR, Real CC, Martins DO, Lopes LR, (2010) Reactive oxygen species and the structural remodeling of the visual system after ocular enucleation. Neuroscience 170: 1249-1260. doi:10.1016/j.neuroscience.2010.07.065. PubMed: 20728508.
23. Iancu R, Mohapel P, Brundin P, Paul G, (2005) Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res 162: 1-10. doi:10.1016/j.bbr.2005.02.023. PubMed: 15922062.
24. Nazemi S, Manaheji H, Zaringhalam J, Sadeghi M, Haghparast A, (2012) Post-injury repeated administrations of minocycline improve the antinociceptive effect of morphine in chronic constriction injury model of neuropathic pain in rat. Pharmacol Biochem Behav 102: 520-525. doi:10.1016/j.pbb.2012.07.001. PubMed: 22789876.
25. Moncunill G, Aponte JJ, Nhabomba AJ, Dobaño C, (2013) Performance of multiplex commercial kits to quantify cytokine and chemokine responses in culture supernatants from Plasmodium falciparum stimulations. PLOS ONE 8: e52587. doi:10.1371/journal.pone.0052587. PubMed: 23300981.
26. Fox C, Dingman A, Derugin N, Wendland MF, Manabat C, et al. (2005) Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 25: 1138-1149. doi:10.1038/sj.jcbfm.9600121. PubMed: 15874975.
27. Hussain AR, Ahmed SO, Ahmed M, Khan OS, Al Abdulmohsen S, et al. (2012) Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis. PLOS ONE 7: e39945. doi:10.1371/journal.pone.0039945. PubMed: 22768179.
28. Hernandes MS, Lima LS, Scavone C, Lopes LR, Britto LR, (2012) Eye enucleation activates the transcription nuclear factor kappa-B in the rat superior colliculus. Neurosci Lett 521: 104-108. doi:10.1016/j.neulet.2012.05.051. PubMed: 22634628.
29. Kawamoto EM, Lima LS, Munhoz CD, Yshii LM, Kinoshita PF, et al. (2012) Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus. J Neurosci Res 90: 213-228. doi:10.1002/jnr.22745. PubMed: 22006678.
30. Munhoz CD, Lepsch LB, Kawamoto EM, Malta MB, Lima Lde S, et al. (2006) Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J Neurosci 26: 3813-3820. doi:10.1523/JNEUROSCI.4398-05.2006. PubMed: 16597735.
31. Glezer I, Munhoz CD, Kawamoto EM, Marcourakis T, Avellar MC, et al. (2003) MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS. Neuropharmacology 45: 1120-1129. doi:10.1016/S0028-3908(03)00279-X. PubMed: 14614955.
32. Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, et al. (2008) Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 5: 15. doi:10.1186/1742-2094-5-15. PubMed: 18477398.
33. Zemke D, Majid A, (2004) The potential of minocycline for neuroprotection in human neurologic disease. Clin Neuropharmacol 27: 293-298. doi:10.1097/01.wnf.0000150867.98887.3e. PubMed: 15613934.
34. He Y, Appel S, Le W, (2001) Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 909: 187-193. doi:10.1016/S0006-8993(01)02681-6. PubMed: 11478935.
35. Laurindo FR, Fernandes DC, Amanso AM, Lopes LR, Santos CX, (2008) Novel role of protein disulfide isomerase in the regulation of NADPH oxidase activity: pathophysiological implications in vascular diseases. Antioxid Redox Signal 10: 1101-1113. doi:10.1089/ars.2007.2011. PubMed: 18373437.
36. Pestana RR, Kinjo ER, Hernandes MS, Britto LR, (2010) Reactive oxygen species generated by NADPH oxidase are involved in neurodegeneration in the pilocarpine model of temporal lobe epilepsy. Neurosci Lett 484: 187-191. doi:10.1016/j.neulet.2010.08.049. PubMed: 20732386.
37. Zeevalk GD, Bernard LP, Song C, Gluck M, Ehrhart J, (2005) Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration. Antioxid Redox Signal 7: 1117-1139. doi:10.1089/ars.2005.7.1117. PubMed: 16115016.
38. Block ML, Li G, Qin L, Wu X, Pei Z, et al. (2006) Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J 20: 251-258. doi:10.1096/fj.05-4553com. PubMed: 16449797.
39. Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, et al. (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci U S A 100: 6145-6150. doi:10.1073/pnas.0937239100. PubMed: 12721370.
40. Zawada WM, Banninger GP, Thornton J, Marriott B, Cantu D, et al. (2011) Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade. J Neuroinflammation 8: 129. doi:10.1186/1742-2094-8-129. PubMed: 21975039.
41. Loeffler DA, DeMaggio AJ, Juneau PL, Havaich MK, LeWitt PA, (1994) Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidation. Clin Neuropharmacol 17: 370-379. doi:10.1097/00002826-199408000-00009. PubMed: 9316685.
42. Lull ME, Block ML, (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics 7: 354-365. doi:10.1016/j.nurt.2010.05.014. PubMed: 20880500.
43. Pranski EL, Dalal NV, Sanford CV, Herskowitz JH, Gearing M, et al. (2013) RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-kappaB signaling in dopaminergic cells. Neurobiol Dis. 54: 264-79.
44. Tarabin V, Schwaninger M, (2004) The role of NF-kappaB in 6-hydroxydopamine- and TNFalpha-induced apoptosis of PC12 cells. Naunyn Schmiedebergs Arch Pharmacol 369: 563-569. doi:10.1007/s00210-004-0938-1. PubMed: 15141332.
45. De Lella Ezcurra AL, Chertoff M, Ferrari C, Graciarena M, Pitossi F, (2010) Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation. Neurobiol Dis 37: 630-640. doi:10.1016/j.nbd.2009.11.018. PubMed: 19969084.
46. Soliman ML, Combs CK, Rosenberger TA, (2013) Modulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes. J Neuroimmune Pharmacol 8: 287-300. doi:10.1007/s11481-012-9426-4. PubMed: 23233245.
47. Guerra MC, Tortorelli LS, Galland F, Da Ré C, Negri E, et al. (2011) Lipopolysaccharide modulates astrocytic S100B secretion: a study in cerebrospinal fluid and astrocyte cultures from rats. J Neuroinflammation 8: 128. doi:10.1186/1742-2094-8-128. PubMed: 21970823.
48. Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, et al. (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 172: 151-154. doi:10.1016/0304-3940(94)90684-X. PubMed: 8084523.
49. Barcia C, Ros CM, Annese V, Gomez A, Ros-Bernal F, et al. (2011) IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death. Drosophila Inf Serv 2: e142.
50. Kim HJ, Park KG, Yoo EK, Kim YH, Kim YN, et al. (2007) Effects of PGC-1alpha on TNF-alpha-induced MCP-1 and VCAM-1 expression and NF-kappaB activation in human aortic smooth muscle and endothelial cells. Antioxid Redox Signal 9: 301-307. doi:10.1089/ars.2006.1456. PubMed: 17184171.
51. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, et al. (2004) A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 6: 97-105. doi:10.1038/ncb1086. PubMed: 14743216.